Cambridge Investment Research Advisors’s iShares MSCI Israel ETF EIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
3,321
+391
+13% +$50K ﹤0.01% 3173
2026
Q1
$340K Buy
2,930
+738
+34% +$88.5K ﹤0.01% 3170
2025
Q4
$241K Buy
2,192
+130
+6% +$13.6K ﹤0.01% 3406
2025
Q3
$207K Sell
2,062
-5,107
-71% -$480K ﹤0.01% 3459
2025
Q2
$680K Buy
+7,169
New +$584K ﹤0.01% 2256
2022
Q1
Sell
-23,338
Closed -$1.82M 3197
2021
Q4
$1.82M Buy
+23,338
New +$1.77M 0.01% 1208
2019
Q2
Sell
-8,076
Closed -$437K 2242
2019
Q1
$437K Buy
8,076
+393
+5% +$20.9K ﹤0.01% 1578
2018
Q4
$372K Sell
7,683
-667
-8% -$35.5K ﹤0.01% 1505
2018
Q3
$468K Buy
+8,350
New +$457K ﹤0.01% 1484

Other funds holding EIS

Cambridge Investment Research Advisors's EIS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its iShares MSCI Israel ETF (EIS) stake by 13% in Q2 2026, buying an estimated $50K and bringing the position to 3,321 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Cambridge Investment Research Advisors first reported a position in EIS in Q3 2018 and has held it in 9 quarters since. The position peaked at $1.82M in Q4 2021. 180 funds tracked by Wall St. Rank hold EIS as of Q2 2026.

  • Cambridge Investment Research Advisors held 3,321 shares of iShares MSCI Israel ETF worth $401K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 391 iShares MSCI Israel ETF shares in Q2 2026, an estimated $50K.
  • iShares MSCI Israel ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3173 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares MSCI Israel ETF in Q3 2018 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's iShares MSCI Israel ETF position peaked at $1.82M in Q4 2021.
  • 180 funds tracked by Wall St. Rank held iShares MSCI Israel ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.